- Sputnik International
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

GlaxoSmithKline Ships First Batch of Experimental Ebola Vaccine to Liberia

© AFP 2023 / POOL/STEVE PARSONS/FILESProfessor Adrian Hill, director of the Jenner Institute and chief investigator of the trials with the Ebola vaccine Chimp Adenovirus type 3 (ChAd3), holds a vial of the vaccine
Professor Adrian Hill, director of the Jenner Institute and chief investigator of the trials with the Ebola vaccine Chimp Adenovirus type 3 (ChAd3), holds a vial of the vaccine - Sputnik International
Subscribe
British pharmaceutical giant GlaxoSmithKline (GSK) sent first batch of experimental Ebola vaccine to Liberia, according to company's official statement.

The company logo of GlaxoSmithKline - Sputnik International
Two Candidate Ebola Vaccines to Be Tested In West Africa in January: WHO
MOSCOW, January 23 (Sputnik) — The first batch of the company’s experimental Ebola vaccine has been shipped to Liberia, one of the West African countries affected by the deadly virus, British pharmaceutical giant GlaxoSmithKline (GSK) said in a statement Friday.

“Shipping the vaccine today [Friday] is a major achievement and shows that we remain on track with the accelerated development of our candidate Ebola vaccine,” Chairman of Global Vaccines at GSK Dr Moncef Slaoui, was quoted as saying in a statement posted on the company’s website.

Moncef added that the candidate Ebola vaccine, co-developed by the US National Institutes of Health, is still in the development phase and mass vaccinations would depend on whether the World Health Organization, and other regulators, were content with the protection it provided against the virus.

Ebola Health Care Workers - Sputnik International
Russia
Russia to Allocate $8 Mln to Efforts to Fight Ebola in 2015
According to the statement, the initial shipment to Liberia contains 300 doses of the Ebola vaccine, to be followed by further shipments, as part of a large-scale vaccination trial expected to involve 30,000 people, including frontline health workers, in the coming weeks.

Based on results of the first clinical trials conducted on some 200 healthy individuals in the United Kingdom, the United States, Switzerland and Mali, the experimental vaccine shows an “acceptable safety profile,” according to the statement.

The current Ebola outbreak has killed over 8,000 people in the three most-affected countries of Liberia, Sierra Leone and Guinea, and over 20,000 probable, suspected and confirmed cases have been reported, according to the World Health Organization.

Meanwhile, the weekly numbers of new Ebola cases reported in all the three countries has declined to its lowest level in recent months.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала